Nasal Decongestants

Nasal Decongestants - Sniffle Stoppers 101

• Definition: Drugs relieving nasal congestion (stuffiness).
• Primary Physiological Effect: Vasoconstriction of nasal mucosal blood vessels, leading to ↓ tissue swelling & improved airflow.
• Mechanism of Action (MOA):
  • Target α-adrenergic receptors (mainly α1) for vasoconstriction.
  • Types:
    • Direct-acting (e.g., Phenylephrine, Oxymetazoline)
    • Indirect-acting (e.g., Ephedrine - enhances norepinephrine release)
    • Mixed-acting (e.g., Pseudoephedrine)

⭐ Nasal decongestants primarily act as alpha-1 adrenergic agonists, causing vasoconstriction of blood vessels in the nasal mucosa.

Nasal Decongestants - The Unclogging Crew

• Mechanism: Sympathomimetics (α-agonists) → nasal vasoconstriction → ↓ edema.
• Types & Examples:
  • Topical (Sprays/Drops):
    • Long-acting (8-12h): Oxymetazoline, Xylometazoline (📌 Oh Xcellent, long relief!)
    • Short-acting (<4h): Phenylephrine, Naphazoline.
    • ⚠️ Use <3-5 days to avoid rhinitis medicamentosa (rebound).
  • Systemic (Oral):
    • Pseudoephedrine, Phenylephrine.
    • ⚠️ Systemic side effects (↑BP, CNS stimulation).

Key Drug Comparison:

Nasal Decongestants - Relief Routes & Rules

• Pharmacokinetics:
  • Topical (e.g., Oxymetazoline, Xylometazoline):
    • Onset: Rapid (minutes).
    • Duration: Shorter.
    • ⚠️ Risk: Rhinitis medicamentosa with use > 3-5 days.
  • Systemic (e.g., Pseudoephedrine, Phenylephrine):
    • Onset: Slower (e.g., Pseudoephedrine ~30 min).
    • Duration: Longer.
    • Metabolism: Pseudoephedrine largely unmetabolized; Phenylephrine extensive first-pass.
• Clinical Applications:
  • Relief of nasal congestion in:
    • Allergic rhinitis
    • Viral rhinitis (common cold)
    • Sinusitis
  • Adjunct in Eustachian tube dysfunction.
• Routes of Administration:
  • Oral (systemic)
  • Nasal sprays/drops (topical)

⭐ Topical nasal decongestants offer rapid onset of action but their use should be limited to 3-5 days to prevent rhinitis medicamentosa.

Nasal Decongestants - Warning Signs & Red Flags

Adverse Effects:

• Topical (Use <5 days):
  • ⚠️ Rhinitis medicamentosa (rebound congestion)
  • Local irritation, stinging, dryness
• Systemic:
  • CNS: Insomnia, anxiety, tremor
  • CV: ↑BP (Hypertension), palpitations, tachycardia
  • Urinary retention (especially with BPH)

Contraindications: ⚠️

• MAOI therapy (concurrent or within 14 days)
• Severe Hypertension / Coronary Artery Disease (CAD)
• Narrow-Angle Glaucoma
• Prostatic Hypertrophy (for systemic agents)
• 📌 Key CIs: MAOIs, Angle-closure glaucoma, Severe HTN/CAD, Prostatic hypertrophy (systemic).

⭐ Systemic decongestants like pseudoephedrine are contraindicated in patients taking MAO inhibitors due to the risk of hypertensive crisis.

Nasal Decongestants - Special Cases & Combos

• Drug Interactions:
  • MAOIs: Hypertensive crisis ⚠️
  • Beta-blockers: ↓ efficacy, paradoxical effects
  • TCAs: Potentiate sympathomimetics
• Special Populations:
  • Children: Caution, age/dose adjustments
  • Pregnancy/Lactation: Pseudoephedrine generally avoided in 1st trimester

⭐ Use of oral decongestants in children, especially those <4 years old, requires caution due to increased risk of adverse effects.

High‑Yield Points - ⚡ Biggest Takeaways

• Nasal decongestants are primarily α-adrenergic agonists causing vasoconstriction of nasal mucosa.
• Key examples: Oxymetazoline, Xylometazoline (topical, long-acting); Phenylephrine, Pseudoephedrine (oral).
• Rhinitis medicamentosa (rebound congestion) is a major risk with prolonged topical use (>3-5 days).
• Systemic side effects (oral): CNS stimulation (insomnia, anxiety), ↑BP, tachycardia.
• Contraindicated with MAO inhibitors, severe hypertension, and coronary artery disease (CAD).
• Use with caution in Benign Prostatic Hyperplasia (BPH), glaucoma, and hyperthyroidism.
• Pseudoephedrine carries a risk of misuse as a methamphetamine precursor and is often restricted.